Georgakopoulos-Soares, Ilias http://orcid.org/0000-0003-3641-1488
Deng, Chengyu
Agarwal, Vikram
Chan, Candace S. Y. http://orcid.org/0000-0001-9667-7996
Zhao, Jingjing
Inoue, Fumitaka http://orcid.org/0000-0003-0657-434X
Ahituv, Nadav http://orcid.org/0000-0002-7434-8144
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1UM1HG011966)
Article History
Received: 4 October 2022
Accepted: 6 April 2023
First Online: 22 April 2023
Competing interests
: N.A. is a cofounder and on the scientific advisory board of Regel Therapeutics. N.A. and I.G.S. are cofounders and on the scientific advisory board of Neomer Diagnostics. N.A. receives funding from BioMarin Pharmaceutical Incorporate. V.A. is an employee of Sanofi Pasteur. The remaining authors do not have competing interests.